Skip to main content
. 2021 Oct 17;88(5):2284–2296. doi: 10.1111/bcp.15087

FIGURE 4.

FIGURE 4

Acalabrutinib AUC24h,ss stratified by adverse event. The numbers below the categories on the x‐axis indicate the number of patients in each category. Open circles show the individual data. The ends of the box are the lower and upper quartiles, the middle line shows the median. The whiskers indicate 1.5 × interquartile range. Data above/below the whiskers are shown as asterisks. AE, adverse event; AUC24h,ss, area under the concentration–time curve at steady‐state conditions for a 24‐hour dosing interval; Gr, grade